LY2922083
LY2922083 and related compounds LY2881835 and LY2922470 are spiperidine and tetrahydroquinolinic acid derivatives that are potent GPR40 agonists. LY2922083 activates GPR40 in response to elevated blood glucose and has the potential to be a glucose-lowering agent[1].
Product Specifications
CAS Number
1309435-78-6
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Free Fatty Acid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/ly2922083.html
Smiles
CC#C[C@H](C1=CC=C(OCC2=CC=C(CN3CCC4(CC3)CCC5=C4C=CC=C5)S2)C=C1)CC(O)=O
Molecular Formula
C31H33NO3S
Molecular Weight
499.66
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
[1]The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB2383-500 1x 500 µL
CD40 / TNFRSF5 / CD40L-Receptor (C40/2383), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
